BioCentury | May 17, 2010
Company News

ChromoCure, Genome Research deal

...Genome Research completed its previously announced reverse-merger with ChromoCure in a deal that the companies said...
...a deal that the companies said is valued at $29 million (see BioCentury, May 3). ChromoCure Inc....
BioCentury | May 3, 2010
Company News

ChromoCure, Genome Research deal

...Genome Research will reverse-merge with ChromoCure in a deal ChromoCure said is valued at more than...
...Genome Research Group. The combined company will use Genome Research's advanced therapeutic modeling protocols and ChromoCure's...
...May 10. In March, the companies signed a Joint Venture and Technology Sharing Agreement granting ChromoCure...
BioCentury | Apr 5, 2010
Company News

ChromoCure, Genome Research Group deal

...The companies signed a Joint Venture and Technology Sharing Agreement granting ChromoCure access to Genome Research's...
...Research will have access to ChromoCure's chromosomal scanner technology for cancer progression analysis. In March, ChromoCure...
...a cancer treatment and R&D company from a cancer detection company (see BioCentury, March 15). ChromoCure Inc....
BioCentury | Mar 15, 2010
Company News

ChromoCure cancer news

...it will transition to a cancer treatment and R&D company from a cancer detection company. ChromoCure's...
...has departed and the company will announce new management "soon." Further details were not disclosed. ChromoCure Inc....
BioCentury | Sep 14, 2009
Company News

ChromoCure deal

...procedures and all hardware designs currently in development related to cancer detection and chromosomal scanning. ChromoCure...
...scanner for the detection of aneuploidy in cancer tissue samples. Further terms were not disclosed. ChromoCure Inc....
Items per page:
1 - 5 of 5
BioCentury | May 17, 2010
Company News

ChromoCure, Genome Research deal

...Genome Research completed its previously announced reverse-merger with ChromoCure in a deal that the companies said...
...a deal that the companies said is valued at $29 million (see BioCentury, May 3). ChromoCure Inc....
BioCentury | May 3, 2010
Company News

ChromoCure, Genome Research deal

...Genome Research will reverse-merge with ChromoCure in a deal ChromoCure said is valued at more than...
...Genome Research Group. The combined company will use Genome Research's advanced therapeutic modeling protocols and ChromoCure's...
...May 10. In March, the companies signed a Joint Venture and Technology Sharing Agreement granting ChromoCure...
BioCentury | Apr 5, 2010
Company News

ChromoCure, Genome Research Group deal

...The companies signed a Joint Venture and Technology Sharing Agreement granting ChromoCure access to Genome Research's...
...Research will have access to ChromoCure's chromosomal scanner technology for cancer progression analysis. In March, ChromoCure...
...a cancer treatment and R&D company from a cancer detection company (see BioCentury, March 15). ChromoCure Inc....
BioCentury | Mar 15, 2010
Company News

ChromoCure cancer news

...it will transition to a cancer treatment and R&D company from a cancer detection company. ChromoCure's...
...has departed and the company will announce new management "soon." Further details were not disclosed. ChromoCure Inc....
BioCentury | Sep 14, 2009
Company News

ChromoCure deal

...procedures and all hardware designs currently in development related to cancer detection and chromosomal scanning. ChromoCure...
...scanner for the detection of aneuploidy in cancer tissue samples. Further terms were not disclosed. ChromoCure Inc....
Items per page:
1 - 5 of 5